NPCE: Neuropace Inc
NPCE exchange rate has changed by 1.02% for today. During the day, the instrument was traded at a low of 14.47 and at a high of 14.90.
Follow Neuropace Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NPCE News
- Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
- NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
- Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?
- NPCE Is Down 12.7% in 3 Months: Is the Pullback a Buying Opportunity?
- NeuroPace, Inc. (NPCE) Q2 2026 Earnings Call Transcript
- NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up
- NeuroPace, Inc. (NPCE) Reports Q2 Loss, Tops Revenue Estimates
- CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
- NeuroPace, Inc. (NPCE) Discusses FDA Feedback on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy Transcript
- Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
- Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 27.88%: Here's is How to Trade
- NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?
- Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
- NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy
- Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
- NPCE Explains How NeuroPace's RNS System Makes Money
- NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
- NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised
- NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript
- NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
- BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
- NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?
- NeuroPace (NPCE) Up 0.9% Since Last Earnings Report: Can It Continue?
- Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
Frequently Asked Questions
What is NPCE stock price today?
Neuropace Inc stock is priced at 14.90 today. It trades within 14.47 - 14.90, yesterday's close was 14.75, and trading volume reached 195. The live price chart of NPCE shows these updates.
Does Neuropace Inc stock pay dividends?
Neuropace Inc is currently valued at 14.90. Dividend policy depends on the company, while investors also watch 40.83% and USD. View the chart live to track NPCE movements.
How to buy NPCE stock?
You can buy Neuropace Inc shares at the current price of 14.90. Orders are usually placed near 14.90 or 15.20, while 195 and 1.92% show market activity. Follow NPCE updates on the live chart today.
How to invest into NPCE stock?
Investing in Neuropace Inc involves considering the yearly range 9.22 - 19.60 and current price 14.90. Many compare 1.36% and 11.78% before placing orders at 14.90 or 15.20. Explore the NPCE price chart live with daily changes.
What are Neuropace Inc stock highest prices?
The highest price of Neuropace Inc in the past year was 19.60. Within 9.22 - 19.60, the stock fluctuated notably, and comparing with 14.75 helps spot resistance levels. Track Neuropace Inc performance using the live chart.
What are Neuropace Inc stock lowest prices?
The lowest price of Neuropace Inc (NPCE) over the year was 9.22. Comparing it with the current 14.90 and 9.22 - 19.60 shows potential long-term entry points. Watch NPCE moves on the chart live for more details.
When did NPCE stock split?
Neuropace Inc has gone through stock splits historically. These changes are visible in , 14.75, and 40.83% after corporate actions.
- Previous Close
- 14.75
- Open
- 14.62
- Bid
- 14.90
- Ask
- 15.20
- Low
- 14.47
- High
- 14.90
- Volume
- 195
- Daily Change
- 1.02%
- Month Change
- 1.36%
- 6 Months Change
- 11.78%
- Year Change
- 40.83%